Table: OncoTherapy Science -2022/23 parent results

OncoTherapy Science

12/05/2023 09:00

May 12 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           9 mln           7 mln                                
               (+27.8 pct)     (-93.4 pct)                             
  Operating     loss 1.09       loss 2.02                              
  Recurring     loss 1.09       loss 2.01                              
  Net           loss 1.12       loss 2.43                              
  EPS         loss 5.80 yen  loss 12.94 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T